IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Hikma Pharmaceuticals PLC SHS (HIK)

CUSIP: G4576K104 | 1 institutional holders

Quarters

Q2 2022Q1 2022
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2022

Captrust Financial Advisors716
0.0% of portfolio›$14
StyleTurnoverLocationFiled
Captrust Financial Advisors
716$140.0%IndexLowRaleigh, NC2022-08-23